603368 Stock Overview
Engages in the wholesale and retail of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
Guangxi LiuYao Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.01 |
| 52 Week High | CN¥24.10 |
| 52 Week Low | CN¥14.53 |
| Beta | 0.42 |
| 11 Month Change | 1.64% |
| 3 Month Change | 13.92% |
| 1 Year Change | -15.37% |
| 33 Year Change | 12.99% |
| 5 Year Change | -24.49% |
| Change since IPO | -55.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603368 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -3.0% | -1.4% | -0.6% |
| 1Y | -15.4% | -15.8% | 3.2% |
Return vs Industry: 603368 matched the CN Healthcare industry which returned -15.8% over the past year.
Return vs Market: 603368 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 603368 volatility | |
|---|---|
| 603368 Average Weekly Movement | 6.1% |
| Healthcare Industry Average Movement | 8.7% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603368 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603368's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 5,582 | Chaoyang Zhu | web.lzyy.cn |
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.
Guangxi LiuYao Group Co., Ltd Fundamentals Summary
| 603368 fundamental statistics | |
|---|---|
| Market cap | CN¥7.18b |
| Earnings (TTM) | CN¥890.92m |
| Revenue (TTM) | CN¥21.19b |
8.1x
P/E Ratio0.3x
P/S RatioIs 603368 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603368 income statement (TTM) | |
|---|---|
| Revenue | CN¥21.19b |
| Cost of Revenue | CN¥18.73b |
| Gross Profit | CN¥2.46b |
| Other Expenses | CN¥1.57b |
| Earnings | CN¥890.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.24 |
| Gross Margin | 11.62% |
| Net Profit Margin | 4.20% |
| Debt/Equity Ratio | 53.8% |
How did 603368 perform over the long term?
See historical performance and comparison